Vogizar-M 0.3 Tablet SR
Marketer
Spectra Therapeutics Pvt Ltd
Salt Composition
Metformin (500mg) + Voglibose (0.3mg)
Overview Vogizar-M 0.3 Tablet SR
DiabetiCare-M 0.3 Extended-Release Tablet is an antidiabetic medication combining multiple agents to manage type 2 diabetes in adults. It regulates blood glucose levels. Always take DiabetiCare-M 0.3 ER with food, consistently at the same time daily for optimal effectiveness. Dosage is determined by your physician and may be adjusted based on your blood sugar response. Continuous use is crucial; discontinuing without medical consultation risks elevated blood sugar, potentially leading to kidney complications, vision impairment, neuropathy, and limb loss. This medication forms part of a comprehensive diabetes management plan including diet, exercise, and weight management as directed by your healthcare provider. Lifestyle choices significantly influence diabetes control. Possible side effects, such as nausea, altered taste, appetite changes, gas, abdominal discomfort, diarrhea, and skin rash, are generally transient. Persistent or concerning side effects warrant immediate medical attention. Your doctor can provide management strategies for any bothersome side effects. This medication is unsuitable for individuals with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Prior heart disease should be disclosed to your physician before commencing treatment. Pregnant or lactating women require medical consultation before use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to assess blood cell counts and liver function.
Uses of Vogizar-M 0.3 Tablet SR
Managing type 2 diabetes
Major Benefits of Vogizar-M 0.3 Tablet SR:
Consume this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the tablet whole; avoid chewing, crushing, or fracturing it. Vogizar-M 0.3mg Extended-Release Tablet should be administered with a meal.
Common Side effects of Vogizar-M 0.3 Tablet SR:
- Flatulence
- Diarrhea
- Abdominal pain
- Vomiting
- Decreased appetite
How to use Vogizar-M 0.3 Tablet SR:
Follow your doctor's instructions precisely regarding dosage and treatment length for Vogizar-M 0.3mg sustained-release tablets. Ingest the tablet whole; do not break, crush, or chew it. Administer this medication with a meal.
How Vogizar-M 0.3 Tablet SR works:
Vogizar-M 0.3mg Extended-Release Tablet contains a dual antidiabetic medication formulation.
SAFETY ADVICE
AlcoholUNSAFE
Consuming alcohol alongside Vogizar-M 0.3 Tablet SR is inadvisable.
PregnancyCONSULT YOUR DOCTOR
The use of Vogizar-M 0.3 Tablet SR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to a developing fetus. A physician will assess the potential advantages against any possible dangers prior to prescribing. Physician consultation is recommended.
Breast feedingCONSULT YOUR DOCTOR
Extended-release Vogizar-M 0.3mg tablets pose a likely risk during lactation. Available human data indicates potential drug transfer to breast milk, with the possibility of infant harm.
DrivingSAFE
The extended-release Vogizar-M 0.3mg tablet typically has no impact on driving ability. Nevertheless, concurrent use with other diabetes medications like sulfonylureas, insulin, or repaglinide necessitates caution due to the potential for low blood sugar.
KidneyCAUTION
Patients with kidney impairment should use Vogizar-M 0.3 mg sustained-release tablets cautiously, potentially requiring dosage modification. Severe kidney disease contraindicates Vogizar-M 0.3 mg SR tablet use. Physician consultation is necessary. Routine monitoring of renal function is recommended during treatment.
LiverCONSULT YOUR DOCTOR
Insufficient data exists regarding Vogizar-M 0.3 Tablet SR use in individuals with hepatic impairment. Physician consultation is advised.
What if you forget to take Vogizar-M 0.3 Tablet SR :
Should you forget a dose of Vogizar-M 0.3 Tablet SR, take it immediately if feasible. Otherwise, if your next dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Vogizar-M 0.3 Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Diabetes Management |
3,018 People bought this recently